Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123275) titled 'PTC technology for predicting the efficacy of therapeutic drugs after EGFR-TKIs resistance in advanced non-small cell lung cancer' on April 23.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Beijing Cancer Hospital
Condition:
NSCLC
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-30
Target Sample Size: Observation group:90;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=320148
Published by HT Digital Content Services with permission from Health Daily Digest....